Showing results (131-140 of 636) with videos related to
Sort By:
Pageof 64
Annals of Neurology|April 5, 2012
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosisAjit Singh Dhaunchak, Christopher Becker, Howard Schulman, et al.Journal of Neuroimmunology|February 11, 2014
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosisDouglas Kazutoshi Sato, Ichiro Nakashima, Amit Bar-Or, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2016
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisRui Li, Ayman Rezk, Mathab Ghadiri, et al.Journal of Neurology|February 9, 2026
Relationship status and the neurobehavioral symptoms of multiple sclerosis: a cross-sectional analysisDavid E Freedman, Jiwon Oh, Anthony FeinsteinNeurodegenerative Disease Management|July 21, 2025
A drug evaluation narrative review of cladribine as a treatment for multiple sclerosisSarah-Jane Martin, Shane Arsenault, Jiwon OhMultiple Sclerosis and Related Disorders|January 7, 2025
Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosisDavid E Freedman, Jiwon Oh, Anthony FeinsteinMultiple Sclerosis (Houndmills, Basingstoke, England)|August 5, 2026
Post-traumatic stress disorder in people with multiple sclerosis: A narrative reviewDavid E Freedman, Jiwon Oh, Anthony FeinsteinThe Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2025
Predictors of Antidepressant Use Among People With Multiple SclerosisDavid E Freedman, Jiwon Oh, Anthony FeinsteinMultiple Sclerosis and Related Disorders|April 10, 2026
How useful is the expanded disability status scale to neuropsychiatrists?David E Freedman, Jiwon Oh, Anthony FeinsteinJournal of Affective Disorders|May 30, 2026
A more optimistic outlook about disease-modifying therapies and depressive symptoms in multiple sclerosis: A cross-sectional analysisDavid E Freedman, Jiwon Oh, Anthony FeinsteinPageof 64